What is Gemcitabine?
Category: Prescription Drugs
Most popular types: Gemzar
See also: Gemcitabine-carboplatin Gemcitabine-paclitaxel GEMOX protocol IGEV regimen
Gemcitabine is an anticancer drug used for breast cancer; nonsmall cell lung cancer or pancreatic cancer; advanced, relapsed ovarian cancer. It is used for Hodgkin’s and non-Hodgkin’s lymphomas, bladder, cervical, hepatobiliary cancers and pleural mesothelioma.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Non-small cell lung cancer | 6 | 0 | |
| Bladder cancer | 4 | 0 | |
| Pancreatic cancer | 4 | 2 | |
| Ovarian cancer | 3 | 1 | |
| Lung cancer | 2 | 0 | |
| Bladder problems | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 1 | |
| None | 0 |
Commonly reported side effects and conditions associated with Gemcitabine
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 3 | |
| Mouth sores (ulcers) | 2 | |
| Brain fog | 1 | |
| Fever | 1 | |
| Hair loss | 1 | |
| Hypersensitivity pneumonitis | 1 |
Why patients stopped taking Gemcitabine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 2 | |
| Course of treatment ended | 1 | |
| Other | 1 |
Duration
Stopped taking Gemcitabine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 | |
| 1 - 6 months | 2 | |
| 2 - 5 years | 1 | |
| 5 - 10 years | 1 |
What people switch to and from
Patients started taking Gemcitabine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| BCG Vaccine (Tice BCG Vaccine) | 1 | |
| Docetaxel (Taxotere) | 1 | |
| Tamoxifen (Tamoxol) | 1 |
Patients stopped taking Gemcitabine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Atezolizumab (Tecentriq) | 1 | |
| Bevacizumab (Avastin) | 1 | |
| Eribulin (Halaven) | 1 | |
| Fluorouracil (Carac) | 1 |
Last updated: